Bridging the gap: How innovation-driven partnerships fuel the pace of cell therapy manufacturing

Client

Product

On this page

Panelists:

Michelle Duquette, PhD, Chief Scientist – Cell Therapy at Invetech (Moderator)

Rob Tressler, Chief Scientific Officer of Excellos

Matthew Hewitt, Vice President, Technical Officer CGT & Biologics at Charles River Laboratories

Emily Titus, Senior Vice President at Notch Therapeutics

Thorsten Gorba, Vice President of Process Development at Aspen Neuroscience

Session Description:

Successfully automating a cell therapy manufacturing program requires flexibility, process understanding, and collaboration to push boundaries and unlock new possibilities. This panel will explore considerations for transitioning to automated systems, developing a roadmap to implementation and how collaborative partnerships can assist in navigating this path, streamlining cell therapy process development and manufacturing.

Ready to get started?

From challenge to breakthrough

Invetech – Get winning diagnostic products to market. Together.

We understand what's required to bring a promising assay from a lab to a commercially ready product. But that alone isn't sufficient for market acceptance: great products demand more....

Invetech – Your diagnostic POC product development partner

For over three decades, our integrated and passionate team of researchers, designers, engineers, scientists, and manufacturing specialists has helped hundreds of clients...

Embracing innovation for a sustainable future in cell therapy

Our mission is to push the boundaries of what's possible in health and life sciences....